394 related articles for article (PubMed ID: 18848337)
21. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
[TBL] [Abstract][Full Text] [Related]
22. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
23. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
24. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
[TBL] [Abstract][Full Text] [Related]
26. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
[TBL] [Abstract][Full Text] [Related]
28. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
Rodo A; Malicka E
Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
[TBL] [Abstract][Full Text] [Related]
31. RAD51 protein expression is increased in canine mammary carcinomas.
Klopfleisch R; Schütze M; Gruber AD
Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
[TBL] [Abstract][Full Text] [Related]
32. p63: a novel myoepithelial cell marker in canine mammary tissues.
Gama A; Alves A; Gartner F; Schmitt F
Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
[TBL] [Abstract][Full Text] [Related]
33. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
[TBL] [Abstract][Full Text] [Related]
34. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma.
Millanta F; Caneschi V; Ressel L; Citi S; Poli A
J Comp Pathol; 2010 Jan; 142(1):36-42. PubMed ID: 19632688
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of microvessel density (MVD) in canine mammary tumours by quantitative immunohistochemistry of the claudin-5 molecule.
Jakab C; Halász J; Kiss A; Schaff Z; Szász AM; Rusvai M; Tóth ZA; Kulka J
Acta Vet Hung; 2008 Dec; 56(4):495-510. PubMed ID: 19149104
[TBL] [Abstract][Full Text] [Related]
37. Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours.
Soini Y
Histopathology; 2005 May; 46(5):551-60. PubMed ID: 15842637
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
[TBL] [Abstract][Full Text] [Related]
39. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
40. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
